Diagnosis and treatment of Helicobacter pylori infection

Peter Bytzer*, Jens Frederik Dahlerup, Jens Ravn Eriksen, Dorte Jarbøl, Steffen Rosenstock, Signe Wildt

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstract

National Danish guidelines for the diagnosis and treatment of Helicobacter pylori (Hp) infection have been approved by the Danish Society for Gastroenterology. All patients with peptic ulcer disease, gastric cancer, and MALT lymphoma should be tested for Hp. We also recommend testing in first degree relatives to patients with gastric cancer, in NSAID-naive patients, who need long-term NSAID therapy, and in patients presenting with dyspepsia and no alarm symptoms. Non-endoscoped patients can be tested with a urea-breath test or a faecal antigen test. Endoscoped patients can be tested with a rapid urease test. PPI therapy should be stopped at least 1 week prior to Hp testing. All infected patients should be offered Hp eradication therapy. Firstline treatment is 7-day triple therapy with a proton pump inhibitor and clarithromycine in combination with metronidazole or amoxicilline. Quadruple therapy for 2 weeks with bismuthsubsalicylate, tetracycline, metronidazole and a proton pump inhibitor is recommended in case of treatment failure. Hp testing should be offered to all patients after eradication therapy but is mandatory in patients with ulcer disease, noninvasive gastric cancer or MALT lymphoma. Testing after eradication should not be done before 4 weeks after treatment has ended.

OriginalsprogEngelsk
TidsskriftDanish medical bulletin
Vol/bind58
Udgave nummer4
StatusUdgivet - 29 apr. 2011

Fingeraftryk

Udforsk hvilke forskningsemner 'Diagnosis and treatment of Helicobacter pylori infection' indeholder.

Citationsformater